BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 16888917)

  • 41. Vascular endothelial growth factor overexpression by soft tissue sarcoma cells: implications for tumor growth, metastasis, and chemoresistance.
    Zhang L; Hannay JA; Liu J; Das P; Zhan M; Nguyen T; Hicklin DJ; Yu D; Pollock RE; Lev D
    Cancer Res; 2006 Sep; 66(17):8770-8. PubMed ID: 16951193
    [TBL] [Abstract][Full Text] [Related]  

  • 42. VEGF and VEGFR-1 are coexpressed by epithelial and stromal cells of renal cell carcinoma.
    Rivet J; Mourah S; Murata H; Mounier N; Pisonero H; Mongiat-Artus P; Teillac P; Calvo F; Janin A; Dosquet C
    Cancer; 2008 Jan; 112(2):433-42. PubMed ID: 18041056
    [TBL] [Abstract][Full Text] [Related]  

  • 43. mTOR inhibitor RAD001 (everolimus) has antiangiogenic/vascular properties distinct from a VEGFR tyrosine kinase inhibitor.
    Lane HA; Wood JM; McSheehy PM; Allegrini PR; Boulay A; Brueggen J; Littlewood-Evans A; Maira SM; Martiny-Baron G; Schnell CR; Sini P; O'Reilly T
    Clin Cancer Res; 2009 Mar; 15(5):1612-22. PubMed ID: 19223496
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vascular endothelial growth factor-mediated decrease in plasma soluble vascular endothelial growth factor receptor-2 levels as a surrogate biomarker for tumor growth.
    Ebos JM; Lee CR; Bogdanovic E; Alami J; Van Slyke P; Francia G; Xu P; Mutsaers AJ; Dumont DJ; Kerbel RS
    Cancer Res; 2008 Jan; 68(2):521-9. PubMed ID: 18199548
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of vascular endothelial growth factors and their receptors in malignant melanomas.
    Brychtova S; Bezdekova M; Brychta T; Tichy M
    Neoplasma; 2008; 55(4):273-9. PubMed ID: 18505336
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
    Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
    Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Xanthine oxidase interaction with vascular endothelial growth factor in human endothelial cell angiogenesis.
    Kou B; Ni J; Vatish M; Singer DR
    Microcirculation; 2008 Apr; 15(3):251-67. PubMed ID: 18386220
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Malignant hematopoietic cells induce an increased expression of VEGFR-1 and VEGFR-3 on bone marrow endothelial cells via AKT and mTOR signalling pathways.
    Mirshahi P; Toprak SK; Faussat AM; Dubrulle S; Marie JP; Soria C; Soria J; Mirshahi M
    Biochem Biophys Res Commun; 2006 Oct; 349(3):1003-10. PubMed ID: 16959214
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Brivanib alaninate, a dual inhibitor of vascular endothelial growth factor receptor and fibroblast growth factor receptor tyrosine kinases, induces growth inhibition in mouse models of human hepatocellular carcinoma.
    Huynh H; Ngo VC; Fargnoli J; Ayers M; Soo KC; Koong HN; Thng CH; Ong HS; Chung A; Chow P; Pollock P; Byron S; Tran E
    Clin Cancer Res; 2008 Oct; 14(19):6146-53. PubMed ID: 18829493
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Colocalization of the VEGF-R2 and the common IL-3/GM-CSF receptor beta chain to lipid rafts leads to enhanced p38 activation.
    Saulle E; Riccioni R; Coppola S; Parolini I; Diverio D; Riti V; Mariani G; Laufer S; Sargiacomo M; Testa U
    Br J Haematol; 2009 May; 145(3):399-411. PubMed ID: 19245429
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An autocrine loop for vascular endothelial growth factor is established in prostate cancer cells generated after prolonged treatment with interleukin 6.
    Steiner H; Berger AP; Godoy-Tundidor S; Bjartell A; Lilja H; Bartsch G; Hobisch A; Culig Z
    Eur J Cancer; 2004 May; 40(7):1066-72. PubMed ID: 15093584
    [TBL] [Abstract][Full Text] [Related]  

  • 52. BMPs promote proliferation and migration of endothelial cells via stimulation of VEGF-A/VEGFR2 and angiopoietin-1/Tie2 signalling.
    Suzuki Y; Montagne K; Nishihara A; Watabe T; Miyazono K
    J Biochem; 2008 Feb; 143(2):199-206. PubMed ID: 18006519
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Receptor tyrosine kinase expression in human bone marrow stromal cells.
    Satomura K; Derubeis AR; Fedarko NS; Ibaraki-O'Connor K; Kuznetsov SA; Rowe DW; Young MF; Gehron Robey P
    J Cell Physiol; 1998 Dec; 177(3):426-38. PubMed ID: 9808151
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Endothelial progenitor cells may inhibit apoptosis of pulmonary microvascular endothelial cells: new insights into cell therapy for pulmonary arterial hypertension.
    Xia L; Fu GS; Yang JX; Zhang FR; Wang XX
    Cytotherapy; 2009; 11(4):492-502. PubMed ID: 19526390
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vascular endothelial growth factor: a therapeutic target for tumors of the Ewing's sarcoma family.
    Dalal S; Berry AM; Cullinane CJ; Mangham DC; Grimer R; Lewis IJ; Johnston C; Laurence V; Burchill SA
    Clin Cancer Res; 2005 Mar; 11(6):2364-78. PubMed ID: 15788688
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cells.
    Fan F; Wey JS; McCarty MF; Belcheva A; Liu W; Bauer TW; Somcio RJ; Wu Y; Hooper A; Hicklin DJ; Ellis LM
    Oncogene; 2005 Apr; 24(16):2647-53. PubMed ID: 15735759
    [TBL] [Abstract][Full Text] [Related]  

  • 57. VEGF expression in adult permanent thyroid cartilage: implications for lack of cartilage ossification.
    Pufe T; Mentlein R; Tsokos M; Steven P; Varoga D; Goldring MB; Tillmann BN; Paulsen FP
    Bone; 2004 Aug; 35(2):543-52. PubMed ID: 15268907
    [TBL] [Abstract][Full Text] [Related]  

  • 58. LRRC4 inhibits glioblastoma cell proliferation, migration, and angiogenesis by downregulating pleiotropic cytokine expression and responses.
    Wu M; Huang C; Li X; Li X; Gan K; Chen Q; Tang Y; Tang K; Shen S; Li G
    J Cell Physiol; 2008 Jan; 214(1):65-74. PubMed ID: 17541939
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer.
    Carrillo de Santa Pau E; Arias FC; Caso Peláez E; Muñoz Molina GM; Sánchez Hernández I; Muguruza Trueba I; Moreno Balsalobre R; Sacristán López S; Gómez Pinillos A; del Val Toledo Lobo M
    Cancer; 2009 Apr; 115(8):1701-12. PubMed ID: 19197998
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of vascular endothelial growth factor and its receptors in the porcine corpus luteum during the estrous cycle and early pregnancy.
    Kaczmarek MM; Kowalczyk AE; Waclawik A; Schams D; Ziecik AJ
    Mol Reprod Dev; 2007 Jun; 74(6):730-9. PubMed ID: 17120307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.